142 related articles for article (PubMed ID: 10906100)
21. The integrin VLA-2 binds echovirus 1 and extracellular matrix ligands by different mechanisms.
Bergelson JM; Chan BM; Finberg RW; Hemler ME
J Clin Invest; 1993 Jul; 92(1):232-9. PubMed ID: 7686920
[TBL] [Abstract][Full Text] [Related]
22. Carcinoembryonic antigen cell adhesion molecule-1 (CEACAM1) in posterior uveal melanoma: correlation with clinical and histological survival markers.
Khatib N; Pe'er J; Ortenberg R; Schachter J; Frenkel S; Markel G; Amer R
Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9368-72. PubMed ID: 22039239
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of tissue inhibitor of matrix metalloproteinases 3 in uveal melanoma.
Nareyeck G; Zeschnigk M; von der Haar D; Schilling H; Bornfeld N; Anastassiou G
Ophthalmic Res; 2005; 37(1):23-8. PubMed ID: 15637418
[TBL] [Abstract][Full Text] [Related]
24. [Immunohistochemical study of VLA integrins in human gastric carcinoma].
Koike N; Saitoh K; Todoroki T; Fukao K; Watanabe T; Nakamura K
Nihon Shokakibyo Gakkai Zasshi; 1994 Dec; 91(12):2183-92. PubMed ID: 7837685
[TBL] [Abstract][Full Text] [Related]
25. Melanoma associated spongiform scleropathy: characterization, biochemical and immunohistochemical studies.
Alyahya GA
Acta Ophthalmol; 2008 Oct; 86 Thesis 3():1-21. PubMed ID: 18826517
[TBL] [Abstract][Full Text] [Related]
26. Integrin expression in cutaneous malignant melanoma: association of the alpha 3/beta 1 heterodimer with tumor progression.
Natali PG; Nicotra MR; Bartolazzi A; Cavaliere R; Bigotti A
Int J Cancer; 1993 Apr; 54(1):68-72. PubMed ID: 8478149
[TBL] [Abstract][Full Text] [Related]
27. Invasive and noninvasive uveal melanomas have different adhesive properties.
Woodward JK; Rennie IG; Elshaw SR; Burn JL; Sisley K
Eye (Lond); 2005 Mar; 19(3):342-8. PubMed ID: 15258612
[TBL] [Abstract][Full Text] [Related]
28. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: simultaneous demonstration of cell surface receptors and their extracellular ligands.
Bonkhoff H; Stein U; Remberger K
Hum Pathol; 1993 Mar; 24(3):243-8. PubMed ID: 7681030
[TBL] [Abstract][Full Text] [Related]
30. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
[TBL] [Abstract][Full Text] [Related]
31. Expression of vascular endothelial growth factor a, matrix metalloproteinase 9 and extravascular matrix patterns in iris and ciliary body melanomas.
Sahin A; Kiratli H; Tezel GG; Soylemezoglu F; Bilgic S
Ophthalmic Res; 2007; 39(1):40-4. PubMed ID: 17164576
[TBL] [Abstract][Full Text] [Related]
32. The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others.
Elices MJ; Hemler ME
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9906-10. PubMed ID: 2557634
[TBL] [Abstract][Full Text] [Related]
33. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma.
Mäkitie T; Summanen P; Tarkkanen A; Kivelä T
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2471-80. PubMed ID: 10509639
[TBL] [Abstract][Full Text] [Related]
34. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4372-5. PubMed ID: 16303922
[TBL] [Abstract][Full Text] [Related]
35. Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas.
Onken MD; Lin AY; Worley LA; Folberg R; Harbour JW
Am J Ophthalmol; 2005 Oct; 140(4):748-9. PubMed ID: 16226537
[TBL] [Abstract][Full Text] [Related]
36. Extracellular matrix receptors and the differentiation of human megakaryocytes in vitro.
Molla A; Mossuz P; Berthier R
Leuk Lymphoma; 1999 Mar; 33(1-2):15-23. PubMed ID: 10194117
[TBL] [Abstract][Full Text] [Related]
37. The microcirculation of choroidal and ciliary body melanomas.
Folberg R; Mehaffey M; Gardner LM; Meyer M; Rummelt V; Pe'er J
Eye (Lond); 1997; 11 ( Pt 2)():227-38. PubMed ID: 9349418
[TBL] [Abstract][Full Text] [Related]
38. Distribution of very late activation integrins in the human cornea. An immunohistochemical study using monoclonal antibodies.
Lauweryns B; van den Oord JJ; Volpes R; Foets B; Missotten L
Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):2079-85. PubMed ID: 2055701
[TBL] [Abstract][Full Text] [Related]
39. A potential role for TGFbeta in the regulation of uveal melanoma adhesive interactions with the hepatic endothelium.
Woodward JK; Rennie IG; Burn JL; Sisley K
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3473-7. PubMed ID: 16186321
[TBL] [Abstract][Full Text] [Related]
40. Tumorigenicity of the mixed spindle-epithelioid SP6.5 and epithelioid TP17 uveal melanoma cell lines is differentially related to alpha5beta1 integrin expression.
Béliveau A; Bérubé M; Carrier P; Mercier C; Guérin SL
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):3058-65. PubMed ID: 11687555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
